Our turnkey solutions bring precision genomics inside hospitals. They allow C-Suite and medical leadership to quickly implement complete value chains, including patient and demand activation, fully managed laboratories and revenue recognition.
With Quantgene, bringing genomics inside becomes quickly profitable and elevates your care quality across the board.
World-leading cancer detection performance beyond the standard of care.
Cancer Genetics
Hereditary cancer solution brings population-wide genetic testing in-house.
Genomic Tumor Profiling
Tumor profiling that elevates your cancer care and saves lives.
For Patients
Quantgene Qx allows you to screen for all cancers with one system. It helps you to detect cancer signals at a much earlier stage by combining precision genomics, imaging, and medical intelligence.
Comprehensive genomics combined with the world's leading medical intelligence for cancer detection.
Qx Plus
Comprehensive genomics combined with full-body MRIs and world leading medical intelligence for cancer detection.
Achievements
R&D Investments
$36 Million
Patient Samples Processed
4950
Clinical research partners
“I believe Quantgene is a unique group of people with great respect for academic research and extensive knowledge of clinical science. Quantgene has been a great partner to me in my academic clinical research and very helpful in our attempt to improve cancer risk determination in high-risk populations of women”
“Quantgene has been pioneering genomics technology at an astonishing pace. I believe the team has built something incredible that can change the future of medicine”
“It’s very rare to come across something with the scale and potential impact of Quantgene. Making genomics intelligent could be a game-changer in not only our fight against cancer but also in our fight with mental health issues, autoimmune and other diseases.”
“We use Quantgene’s genomics technology in my clinical research for early cancer detection, and I couldn’t think of a better partner. Using Genomics for early detection is one of the most promising innovation pathways to reduce cancer deaths in America.”